CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV

BMC Gastroenterology
Chia-Chen LinI-Shyan Sheen

Abstract

Chemokines/cytokines play important roles in the pathogenesis of chronic hepatitis C (CHC). However, their clinical characteristics and implications in treatment responses to pegylated interferon plus ribavirin treatment (PegIFN/RBV) have not been fully illustrated yet. In this study, we intended to investigate the possible predictability of serum chemokines/cytokines on the treatment response in Taiwanese of CHC, genotype-1 (GT-1). 60 Patients with GT-1 CHC infection who had been treated with PegIFN/RBV were enrolled, including 27 (45%) with sustained virological response (SVR), 11 (18%) with relapse after 48 weeks of treatment and 22 (37%) non-response (NR). Clinical parameters, seven chemokines/cytokines, CCL3, CCL4, CXCL9, CXCL10, CXCL11, IL-10 and IFN-γ, and genotypes of rs12979860, the single nucleotide polymorphisms (SNPs) of interleukin-28B (IL28B) were analyzed for their relationship to treatment response. Baseline serum levels of CXCL10, CXCL11, CCL3 and CCL4 were significantly higher in NR group while comparing with non-NR group. (CXCL10: p = 0.001; CXCL11: p < 0.001; CCL3: p = 0.006; CCL4: p = 0.005). However, only rs12979860 CC genotype was the independent factors for NR in GT-1 CHC infection (OR, 8.985; p = 0.008)...Continue Reading

References

Jul 7, 2001·The New England Journal of Medicine·G M Lauer, B D Walker
Dec 31, 2003·Lancet·Thierry PoynardChing Lung Lai
Feb 10, 2006·The New England Journal of Medicine·Israel F Charo, Richard M Ransohoff
Nov 21, 2007·Journal of Viral Hepatitis·E Jenny Heathcote
Dec 17, 2008·World Journal of Gastroenterology : WJG·Juan R LarrubiaTrinidad Parra-Cid
Apr 2, 2009·Journal of Gastroenterology and Hepatology·Ming-Lung Yu, Wan-Long Chuang
Dec 17, 2009·Gut·Alessandra Mangia, Angelo Andriulli
Mar 12, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J FlorholmenR Goll
Jul 27, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul J PockrosAnna S Lok
Jan 19, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Tarik Asselah, Patrick Marcellin
Dec 12, 2013·Journal of Gastroenterology and Hepatology·Kentaro MatsuuraYasuhito Tanaka
Aug 29, 2014·Therapeutic Advances in Infectious Disease·Astrid Wendt, Marc Bourlière
Dec 3, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shibin ZhangXinyue Chen
Jun 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN AASLD/IDSA HCV Guidance Panel
Jan 5, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Tarik AsselahPatrick Marcellin

❮ Previous
Next ❯

Citations

Jul 27, 2021·Frontiers in Cellular and Infection Microbiology·Andréa Marques Vieira da SilvaMilton Ozório Moraes

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR

Software Mentioned

VERSANT
SPSS

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.